B C BIOSIMILARS COUNCIL A DIVISION OF AAM
Dead / Abandoned — Abandoned — failure to respond (as of 26 Feb 2024)
What this means for you
This application is over — abandoned 09 Feb 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97295418
- Mark type
- Design + words
- Filed
- 04 Mar 2022
- Abandoned
- 09 Feb 2024
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 035 — Advertising and business services: Association services, namely, promoting awareness of biosimilars in the United States with the intent of expanding access to and availability of biological medicines and improving health care; providing information to inform and support public policies that encourage awareness of, access to, and adoption of biosimilars; promoting the interest of biosimilars development and adoption by means of public advocacy
Owner
- Association for Accessible Medicines, Washington, DC, US
Prosecution history
- 26 Feb 2024 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 26 Feb 2024 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 02 Nov 2023 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 02 Nov 2023 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 08 Aug 2023 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 08 Aug 2023 — FINAL REFUSAL E-MAILED
- 08 Aug 2023 — FINAL REFUSAL WRITTEN
- 27 Jun 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 26 Jun 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 26 Jun 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 09 Mar 2023 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 09 Mar 2023 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 27 Dec 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 27 Dec 2022 — NON-FINAL ACTION E-MAILED
- 27 Dec 2022 — NON-FINAL ACTION WRITTEN